“Long-term yoghurt intake may be differentially associated with the incidence of proximal colon cancer according to Bifidobacterium abundance, suggesting the antitumor effect of yoghurt intake on the specific tumour subgroup,” the study noted.
People who consumed two or more servings of yoghurt weekly had a 20 per cent lower incidence of Bifidobacterium-positive proximal colon cancer – a notable type of colorectal cancer with dire implications for patient survival rates.
The research, published in the journal Gut Microbes, found that incorporating yoghurt into daily diet could strengthen the body’s defences against colorectal cancer by fostering a diverse gut microbiome.
Consuming yoghurt regularly may reduce bowel cancer risk by altering the body’s gut bacteria, a new study has found.
The data enabled researchers to conduct a comprehensive review of the relationship between yoghurt intake and bowel cancer risk.
